Price Wealth’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-281,628
Closed -$286K 455
2020
Q2
$286K Buy
281,628
+281,607
+1,340,986% +$75.1M 0.08% 69
2020
Q1
$5K Sell
21
-4
-16% -$1.09K ﹤0.01% 203
2019
Q4
$8K Buy
25
+8
+47% +$2.2K ﹤0.01% 174
2019
Q3
$4K Sell
17
-281,613
-100% -$77.2M ﹤0.01% 216
2019
Q2
$287K Buy
281,630
+17
+0% +$4.64K 0.09% 66
2019
Q1
$282K Buy
+281,613
New +$81.4M 0.11% 59
2018
Q3
Sell
-281,801
Closed -$327K 244
2018
Q2
$327K Buy
+281,801
New +$65.3M 0.12% 68

Other funds holding ELV

Price Wealth's ELV Position: Q3 2020 in Review

Price Wealth sold out of Elevance Health (ELV) in Q3 2020, closing a stake of 281,628 shares — an estimated $286K sold.

Price Wealth first reported a position in ELV in Q2 2018 and held it in 7 quarters. The position peaked at $327K in Q2 2018. 1,094 funds tracked by Wall St. Rank hold ELV as of Q3 2020.

  • Price Wealth reported no remaining Elevance Health position as of Q3 2020 after selling out during the quarter.
  • Price Wealth sold 281,628 Elevance Health shares in Q3 2020, an estimated $286K.
  • Price Wealth first reported a position in Elevance Health in Q2 2018 and held it in 7 quarters.
  • Price Wealth's Elevance Health position peaked at $327K in Q2 2018.
  • 1,094 funds tracked by Wall St. Rank held Elevance Health as of Q3 2020.

Based on Price Wealth's 13F filing for Q3 2020, filed 22 Oct 2020.